This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Acambis Research Limited. Active years: 2011-2012.
Company Filing History:
Years Active: 2011-2012
Title: Innovations of Jonathan Clive Stephens
Introduction
Jonathan Clive Stephens is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of vaccine development, particularly through his innovative work with attenuated bacteria. With a total of 3 patents, his inventions aim to combat diarrheal diseases effectively.
Latest Patents
One of his latest patents is focused on attenuated bacteria useful in vaccines. This invention provides strains of bacteria, especially enterotoxigenic, that are attenuated by mutations in the genes encoding enterotoxins (LT, ST, EAST1). Additionally, these strains can be further attenuated by the deletion of additional chromosomal genes. The invention also includes strains of attenuated bacteria that express immunogenic but non-toxic variants of one or more of these enterotoxins, making them useful as a vaccine against diarrheal disease. Another significant patent is for a bacterial vaccine, which involves a bacterial cell that expresses three or more coli surface (CS) antigens. This cell is beneficial in creating vaccines against diarrhea.
Career Highlights
Jonathan Clive Stephens is associated with Acambis Research Limited, where he continues to work on innovative solutions in the field of vaccines. His research has been pivotal in advancing the understanding and treatment of diarrheal diseases.
Collaborations
He has collaborated with notable coworkers such as Arthur Keith Turner and Judith Greenwood, contributing to the collective expertise in vaccine research and development.
Conclusion
Jonathan Clive Stephens is a prominent inventor whose work in vaccine development has the potential to significantly impact public health. His innovative patents reflect his commitment to addressing critical health challenges.